U.S Holds the Largest Share of the Dermatology Treatment Devices Market

Date: 2015-07-30

“The North American dermatology treatment devices market is estimated to grow at a CAGR of 10.1% from 2014 to 2019. The U.S holds the largest share of the dermatology treatment devices market; however, the Canadian market is expected to grow at the highest CAGR of 11.5% during the forecast period. Factors such as rising skin disorders, growing demand for diagnosis from the geriatric population, increasing demand for dermatologists, and technology advantages are driving market growth. However, factors such as lack of awareness, competitive pricing of devices, and lack of dermatology care are hindering the growth of this market. 

In this report, the North American dermatology treatment devices market has been broadly classified on the basis of types. This includes LED light therapy devices, lasers, electrosurgical equipment, liposuction devices, microdermabrasion, and cryotherapy. The lasers segment held the largest share in the treatment devices market, growing at a CAGR of 12.3% during the forecast period. 

Geographically, the U.S commanded the largest share of 86.0% of the North American dermatology treatment devices market in 2014, followed by Canada. The dermatology treatment devices market in the U.S. is primarily driven by increasing demand from the geriatric population and rise in insurance coverage among citizens due to increasing employment. Canada is the fastest-growing market in the North American region, growing at a CAGR of 11.5% during the forecast period. 

The North American dermatology treatment devices market is a competitive market with a number of market players. As of 2014, the North American dermatology treatment devices market is estimated to be dominated by Photomedex, Inc., Verisante technology, Inc., MELA Sciences, Inc., Michelson diagnostics Ltd, Leica Microsystems, Fotofinder systems GMBH, FEI Company, Solta medical, Syneron medical Ltd., Lumenis Ltd., Cutera, Inc., Cynosure, Inc., AMD global telemedicine Inc, Ambicare Health Ltd, and ALMA Lasers, Ltd.

Reasons to Buy the Report: 
From an insight perspective, this research report has focused on various levels of analysis—market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging- and high-growth segments of the dermatology treatment devices market, high-growth regions their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market, share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share. 

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on treatment devices offered by the top players in the Dermatology  treatment devices market 

• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the dermatology treatment devices market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various dermatology treatment devices across geographies

• Market Diversification: Exhaustive information about new products, recent developments, and investments in the dermatology treatment devices market 

• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the dermatology treatment devices market 

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample